Search Page

1

Cite

Share

Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.

Buus R, Sestak I, Kronenwett R, Ferree S, Schnabel CA, Baehner FL, Mallon EA, Cuzick J, Dowsett M. Buus R, et al. Among authors: mallon ea. J Clin Oncol. 2021 Jan 10;39(2):126-135. doi: 10.1200/JCO.20.00853. Epub 2020 Oct 27. J Clin Oncol. 2021. PMID: 33108242 Free PMC article.

Cite

Share

2

Cite

Share

Authors' reply.

Spears M, Cunningham CA, Taylor KJ, Mallon EA, Thomas JS, Kerr GR, Jack WJ, Kunkler IH, Cameron DA, Chetty U, Bartlett JM. Spears M, et al. Among authors: mallon ea. J Pathol. 2013 Feb;229(3):e2-3. doi: 10.1002/path.4144. J Pathol. 2013. PMID: 23152120 No abstract available.

Cite

Share

3

Cite

Share

Nasal leishmaniasis.

Vernham GA, Sadiq H, Mallon EA. Vernham GA, et al. Among authors: mallon ea. J Laryngol Otol. 1993 Sep;107(9):834-6. doi: 10.1017/s0022215100124569. J Laryngol Otol. 1993. PMID: 8228603

Cite

Share

4

Cite

Share

What the clinician needs from the pathologist: evidence-based reporting in breast cancer.

Going JJ, Mallon EA, Leake RE, Bartlett JM, Gusterson BA. Going JJ, et al. Among authors: mallon ea. Eur J Cancer. 2001 Oct;37 Suppl 7:S5-17. doi: 10.1016/s0959-8049(01)80003-4. Eur J Cancer. 2001. PMID: 11888005 Review.

Cite

Share

5

Cite

Share

Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.

Roseweir AK, Bennett L, Dickson A, Cheng K, Quintayo MA, Bayani J, McMillan DC, Horgan PG, van de Velde CJH, Seynaeve C, Hasenburg A, Kieback DG, Markopoulos C, Dirix LY, Rea DW, Mallon EA, Bartlett JMS, Edwards J. Roseweir AK, et al. Among authors: mallon ea. J Natl Cancer Inst. 2018 Jun 1;110(6):616-627. doi: 10.1093/jnci/djx255. J Natl Cancer Inst. 2018. PMID: 29917140 Clinical Trial.

Cite

Share

6

Cite

Share

An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions.

Foley NM, Racz JM, Al-Hilli Z, Livingstone V, Cil T, Holloway CM, Romics L Jr, Matrai Z, Bennett MW, Duddy L, Nofech-Mozes S, Slodkowska E, Mallon EA, Dawson N, Roche T, Relihan N, Hill AD, Redmond HP, Corrigan MA. Foley NM, et al. Among authors: mallon ea. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S385-90. doi: 10.1245/s10434-015-4773-z. Epub 2015 Aug 4. Ann Surg Oncol. 2015. PMID: 26240010

Cite

Share

7

Cite

Share

Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction.

Romics L Jr, Chew BK, Weiler-Mithoff E, Doughty JC, Brown IM, Stallard S, Wilson CR, Mallon EA, George WD. Romics L Jr, et al. Among authors: mallon ea. Br J Surg. 2012 Jun;99(6):799-806. doi: 10.1002/bjs.8704. Epub 2012 Feb 24. Br J Surg. 2012. PMID: 22367773

Cite

Share

8

Cite

Share

Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer.

Roseweir AK, McCall P, Scott A, Liew B, Lim Z, Mallon EA, Edwards J. Roseweir AK, et al. Among authors: mallon ea. Oncotarget. 2017 Jun 6;8(23):37172-37185. doi: 10.18632/oncotarget.16420. Oncotarget. 2017. PMID: 28415597 Free PMC article.

Cite

Share

9

Cite

Share

Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours.

Tovey SM, Brown S, Doughty JC, Mallon EA, Cooke TG, Edwards J. Tovey SM, et al. Among authors: mallon ea. Br J Cancer. 2009 Mar 10;100(5):680-3. doi: 10.1038/sj.bjc.6604940. Epub 2009 Feb 17. Br J Cancer. 2009. PMID: 19223897 Free PMC article.

Cite

Share

10

Cite

Share

High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer.

Bennett L, Quinn J, McCall P, Mallon EA, Horgan PG, McMillan DC, Paul A, Edwards J. Bennett L, et al. Among authors: mallon ea. Int J Cancer. 2017 Apr 1;140(7):1633-1644. doi: 10.1002/ijc.30578. Epub 2017 Jan 6. Int J Cancer. 2017. PMID: 28006839 Free article.

Cite

Share